Greg Blake has extensive commercial and operational leadership experience within the pharmaceutical and biotech sectors in Australia and internationally. He has led the strategic development and commercialisation of a number of products across a range of therapeutic categories.
During his 20 years of work in the healthcare sector, Mr Blake has built a solid foundation of knowledge across marketing and the entire commercial value chain. His work with Rhythm Biosciences as general manager led
the company through the establishment of the pre-launch critical pathway and commercialisation planning for the domestic and international markets. As marketing lead (Europe) of Mundipharma International, he successfully led 26 European countries through the pre-launch and launch phases for a novel pain medication. Mr Blake had also held leadership roles at large multinationals (J&J and CSL) and publicllisted biotech startups.
